UBS Group
ZURAW

UBS Group’s Zura Bio Limited Warrants ZURAW Stock Holding History

UBS Group’s Portfolio ZURAW Stock Details ZURAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100
Closed – – 11308
2022
Q3 		$0 Hold
100
– – ﹤0.01% 11148
2022
Q2 		$0 Hold
100
– – ﹤0.01% 11160
2022
Q1 		$0 Buy
+100
New +$42 ﹤0.01% 11099

Other funds holding ZURAW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

UBS Group's ZURAW Position: Q4 2022 in Review

UBS Group sold out of Zura Bio Limited Warrants (ZURAW) in Q4 2022, closing a stake of 100 shares.

UBS Group first reported a position in ZURAW in Q1 2022 and held it in 3 quarters. The position peaked at $0 in Q3 2022. 25 funds tracked by Wall St. Rank hold ZURAW as of Q4 2022.

  • UBS Group reported no remaining Zura Bio Limited Warrants position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 100 Zura Bio Limited Warrants shares in Q4 2022.
  • UBS Group first reported a position in Zura Bio Limited Warrants in Q1 2022 and held it in 3 quarters.
  • UBS Group's Zura Bio Limited Warrants position peaked at $0 in Q3 2022.
  • 25 funds tracked by Wall St. Rank held Zura Bio Limited Warrants as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.